Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001553350-19-000576
Filing Date
2019-05-20
Accepted
2019-05-20 17:24:18
Documents
48
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ephs_10q.htm 10-Q 300332
2 CERTIFICATION ephs_ex31z1.htm EX-31 8269
3 CERTIFICATION ephs_ex31z2.htm EX-31.2 8271
4 CERTIFICATION ephs_ex32z1.htm EX-32 3584
5 CERTIFICATION ephs_ex32z2.htm EX-32.2 3606
  Complete submission text file 0001553350-19-000576.txt   1789369

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE stnn-20190331.xml EX-101.INS 233054
7 XBRL SCHEMA FILE stnn-20190331.xsd EX-101.SCH 21360
8 XBRL CALCULATION FILE stnn-20190331_cal.xml EX-101.CAL 41188
9 XBRL DEFINITION FILE stnn-20190331_def.xml EX-101.DEF 55354
10 XBRL LABEL FILE stnn-20190331_lab.xml EX-101.LAB 183645
11 XBRL PRESENTATION FILE stnn-20190331_pre.xml EX-101.PRE 132907
Mailing Address 5490 NOTRE DAME EST MONTREAL A8 H1N 2C4
Business Address 5490 NOTRE DAME EST MONTREAL A8 H1N 2C4 212-321-0091
EPHS HOLDINGS, INC. (Filer) CIK: 0001731911 (see all company filings)

EIN.: 824383947 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55906 | Film No.: 19839908
SIC: 2834 Pharmaceutical Preparations